A

Amneal Intermediate Inc
NASDAQ:AMRX

Watchlist Manager
Amneal Intermediate Inc
NASDAQ:AMRX
Watchlist
Price: 8.46 USD -2.76% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Amneal Intermediate Inc?
Write Note

Amneal Intermediate Inc
Total Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Amneal Intermediate Inc
Total Liabilities Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Total Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
A
Amneal Intermediate Inc
NASDAQ:AMRX
Total Liabilities
$3.5B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
34%
Johnson & Johnson
NYSE:JNJ
Total Liabilities
$109.6B
CAGR 3-Years
0%
CAGR 5-Years
2%
CAGR 10-Years
7%
Bristol-Myers Squibb Co
NYSE:BMY
Total Liabilities
$77.6B
CAGR 3-Years
2%
CAGR 5-Years
15%
CAGR 10-Years
16%
Pfizer Inc
NYSE:PFE
Total Liabilities
$128.5B
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
3%
Merck & Co Inc
NYSE:MRK
Total Liabilities
$69B
CAGR 3-Years
6%
CAGR 5-Years
4%
CAGR 10-Years
3%
Eli Lilly and Co
NYSE:LLY
Total Liabilities
$58.3B
CAGR 3-Years
12%
CAGR 5-Years
10%
CAGR 10-Years
13%

See Also

What is Amneal Intermediate Inc's Total Liabilities?
Total Liabilities
3.5B USD

Based on the financial report for Dec 31, 2023, Amneal Intermediate Inc's Total Liabilities amounts to 3.5B USD.

What is Amneal Intermediate Inc's Total Liabilities growth rate?
Total Liabilities CAGR 10Y
34%

Over the last year, the Total Liabilities growth was -1%. The average annual Total Liabilities growth rates for Amneal Intermediate Inc have been -2% over the past three years , -2% over the past five years , and 34% over the past ten years .

Back to Top